Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CollabNet was a pioneer in the enterprise cloud development and DevOps space, widely recognized for its role in founding the Subversion (SVN) version control system. Headquartered in the biotechnology hub of South San Francisco, the company provided the TeamForge Application Lifecycle Management (ALM) platform, which became a standard for collaborative software development in highly regulated industries. In the life sciences and healthcare sectors, CollabNet's solutions were specifically leveraged to ensure compliance with FDA 21 CFR Part 11 and other GxP regulatory standards by providing rigorous traceability and audit trails. The company's focus on "Compliance-ready DevOps" allowed biotech and pharmaceutical firms to accelerate software-driven innovation while maintaining safety and quality requirements. In 2019, CollabNet was acquired by TPG Capital and subsequently merged with XebiaLabs and Arxan Technologies to form Digital.ai in 2020.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CollabNet.